Regeneron Pharmaceuticals (REGN) Tax Rate (2011 - 2026)

Regeneron Pharmaceuticals' Tax Rate history runs 16 years deep, the most recent figure standing at 15.11% for Q2 2026.

• In Q2 2026, Tax Rate rose 674.0% year-over-year to 15.11%; the TTM figure through Jun 2026 stood at 16.21% (up 767.0% YoY), while the FY2025 annual figure was 13.88%, up 619.0% from the prior year.
• Tax Rate for Q2 2026 stood at 15.11%, up from 12.51% in the prior quarter.
• The five-year high for Tax Rate was 19.08% in Q4 2025, with the low at 3.04% in Q1 2024.
• The 5-year median for Tax Rate is 10.39% (2023), against an average of 9.56%.
• The sharpest annual moves came in 2023 and 2025: Tax Rate tumbled 1068 bps in 2023, then jumped 1486 bps in 2025.
• Regeneron Pharmaceuticals' Tax Rate stood at 9.63% in 2022, then slumped by 111 bps to 1.05% in 2023, then soared by 503 bps to 4.22% in 2024, then surged by 352 bps to 19.08% in 2025, then dropped by 21 bps to 15.11% in 2026.
• Business Quant data shows REGN's Tax Rate at 15.11% in Q2 2026, 12.51% in Q1 2026, and 19.08% in Q4 2025.